Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.

Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Behrens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA.

Pharmacogenetics. 2002 Aug;12(6):429-36.

PMID:
12172211
[PubMed - indexed for MEDLINE]
2.

[Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease].

Gisbert JP, González-Lama Y, Maté J.

Gastroenterol Hepatol. 2006 Nov;29(9):568-83. Review. Spanish.

PMID:
17129552
[PubMed - indexed for MEDLINE]
3.

Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?

Sanderson J, Ansari A, Marinaki T, Duley J.

Ann Clin Biochem. 2004 Jul;41(Pt 4):294-302. Review.

PMID:
15298741
[PubMed - indexed for MEDLINE]
4.

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.

Gearry RB, Barclay ML.

J Gastroenterol Hepatol. 2005 Aug;20(8):1149-57. Review.

PMID:
16048561
[PubMed - indexed for MEDLINE]
5.

Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease.

Dong XW, Zheng Q, Zhu MM, Tong JL, Ran ZH.

World J Gastroenterol. 2010 Jul 7;16(25):3187-95. Review.

PMID:
20593505
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.

Teml A, Schaeffeler E, Herrlinger KR, Klotz U, Schwab M.

Clin Pharmacokinet. 2007;46(3):187-208. Review.

PMID:
17328579
[PubMed - indexed for MEDLINE]
7.

Genetic testing in Crohn disease: utility in individualizing patient management.

Mascheretti S, Schreiber S.

Am J Pharmacogenomics. 2005;5(4):213-22. Review.

PMID:
16078858
[PubMed - indexed for MEDLINE]
8.

Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy.

Baker DE.

Rev Gastroenterol Disord. 2003 Summer;3(3):150-7. Review.

PMID:
14502119
[PubMed - indexed for MEDLINE]
9.

Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.

Clunie GP, Lennard L.

Rheumatology (Oxford). 2004 Jan;43(1):13-8. Epub 2003 Oct 17. Review.

PMID:
14566029
[PubMed - indexed for MEDLINE]
Free Article
10.

Thiopurines in Crohn's disease, is there something new?

Miheller P, Lakatos PL.

Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1505-14. doi: 10.1517/17425255.2010.525505. Epub 2010 Oct 5. Review.

PMID:
20919963
[PubMed - indexed for MEDLINE]
11.

[Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine].

Bessard G, Hardy G, Chartier A, Stanke-Labesque F.

Therapie. 2004 Jan-Feb;59(1):71-5. Review. French.

PMID:
15199672
[PubMed - indexed for MEDLINE]
12.

Clinical utility of thiopurine S-methyltransferase genotyping.

Corominas H, Baiget M.

Am J Pharmacogenomics. 2004;4(1):1-8. Review.

PMID:
14987117
[PubMed - indexed for MEDLINE]
13.

Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come.

Ford LT, Berg JD.

J Clin Pathol. 2010 Apr;63(4):288-95. doi: 10.1136/jcp.2009.069252. Review.

PMID:
20354201
[PubMed - indexed for MEDLINE]
14.

Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD.

Benkov K, Lu Y, Patel A, Rahhal R, Russell G, Teitelbaum J; NASPGHAN Committee on Inflammatory Bowel Disease.

J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):333-40. doi: 10.1097/MPG.0b013e3182844705. Review. Erratum in: J Pediatr Gastroenterol Nutr. 2013 May;56(5):582.

PMID:
23287804
[PubMed - indexed for MEDLINE]
15.

Comparative tolerability of therapies for ulcerative colitis.

Ardizzone S, Bianchi Porro G.

Drug Saf. 2002;25(8):561-82. Review.

PMID:
12113642
[PubMed - indexed for MEDLINE]
16.

Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.

Chouchana L, Narjoz C, Beaune P, Loriot MA, Roblin X.

Aliment Pharmacol Ther. 2012 Jan;35(1):15-36. doi: 10.1111/j.1365-2036.2011.04905.x. Epub 2011 Nov 2. Review.

PMID:
22050052
[PubMed - indexed for MEDLINE]
17.

Pharmacogenetics in inflammatory bowel disease.

Pierik M, Rutgeerts P, Vlietinck R, Vermeire S.

World J Gastroenterol. 2006 Jun 21;12(23):3657-67. Review.

PMID:
16773681
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.

Krynetski EY, Tai HL, Yates CR, Fessing MY, Loennechen T, Schuetz JD, Relling MV, Evans WE.

Pharmacogenetics. 1996 Aug;6(4):279-90. Review.

PMID:
8873214
[PubMed - indexed for MEDLINE]
19.

The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.

Coulthard SA, Matheson EC, Hall AG, Hogarth LA.

Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1385-91. Review.

PMID:
15571264
[PubMed - indexed for MEDLINE]
20.

Assessment of thiopurine methyltransferase activity in patients prescribed azathioprine or other thiopurine-based drugs.

Booth RA, Ansari MT, Tricco AC, Loit E, Weeks L, Doucette S, Skidmore B, Hoch JS, Tsouros S, Sears M, Sy R, Karsh J, Mani S, Galipeau J, Yurkiewich A, Daniel R, Tsertsvadze A, Yazdi F.

Evid Rep Technol Assess (Full Rep). 2010 Dec;(196):1-282. Review.

PMID:
23126559
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk